Misonix, Inc.  

(Public, NASDAQ:MSON)   Watch this stock  
Find more results for COVIDIEN INC
5.83
-0.40 (-6.48%)
Feb 12 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.79 - 6.20
52 week 5.79 - 13.90
Open 6.20
Vol / Avg. 53,188.00/12,656.00
Mkt cap 43.30M
P/E 12.10
Div/yield     -
EPS 0.48
Shares 7.79M
Beta -0.02
Inst. own 15%
May 5, 2016
Q3 2016 Misonix Inc Earnings Release (Estimated) Add to calendar
Feb 9, 2016
Q2 2016 Misonix Inc Earnings Call - Webcast
Feb 9, 2016
Q2 2016 Misonix Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 2.89% 23.89%
Operating margin -16.18% -7.72%
EBITD margin - -1.24%
Return on average assets 2.60% 23.07%
Return on average equity 2.88% 26.45%
Employees 80 -
CDP Score - -

Address

1938 New Hwy
FARMINGDALE, NY 11735-1204
United States - Map
+1-516-6949555 (Phone)
+1-631-6949412 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

MISONIX, INC. (Misonix), designs, manufactures, develops and markets minimally invasive ultrasonic surgical device products. These products include the BoneScalpel cutting systemwhich is used among other things for surgical procedures of the spine and on maxillofacial procedures, the SonaStar Surgical Aspirator which is used to emulsify and remove soft and hard tumors, the SonicOne Wound Cleansing and Debridement System that offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells, and the AutoSonix ultrasound cutting and coagulating system, which is distributed and marketed for Misonix through an agreement with Covidien Ltd. Misonix also markets its Lysonix soft tissue aspirator used for cosmetic surgery through Mentor Corporation, a subsidiary of Johnson & Johnson . The Company sold its Laboratory and Forensic Safety Products business to Mystaire, Inc.

Officers and directors

Michael A. McManus Jr. Chairman of the Board, President, Chief Executive Officer
Age: 72
Bio & Compensation  - Reuters
Richard A. Zaremba Chief Financial Officer, Senior Vice President, Secretary, Treasurer
Age: 60
Bio & Compensation  - Reuters
Joseph J. Brennan Vice President - Operations
Age: 51
Bio & Compensation  - Reuters
Robert Scott Ludecker Vice President - Global Sales and Marketing
Age: 48
Bio & Compensation  - Reuters
Michael L. Consilvio Vice President of Marketing
Age: 52
Bio & Compensation  - Reuters
John J. Salerno Vice President of Quality and Regulatory Affairs
Age: 60
Bio & Compensation  - Reuters
Daniel Voic Vice President - Research & Development and Engineering
Age: 53
Bio & Compensation  - Reuters
Stavros G. Vizirgianakis Director
Age: 45
Bio & Compensation  - Reuters
John W. Gildea Independent Director
Age: 72
Bio & Compensation  - Reuters
Patrick A. McBrayer Independent Director
Age: 63
Bio & Compensation  - Reuters